Home / KEEP BUT DO NOT DISPLAY / Alerts / Second DPP-4 inhibitor gets FDA Approval

Second DPP-4 inhibitor gets FDA Approval

Aug 2, 2009
 

2nd DPP-4 inhibitor gets FDA Approval
Onglyza™ (saxagliptin) a new DPP-4 inhibitor similar to Januvia will give physicians another option in treating their patients with diabetes. See This Week’s Item #1.